Literature DB >> 27195609

Use of the NASA Space Radiation Laboratory at Brookhaven National Laboratory to Conduct Charged Particle Radiobiology Studies Relevant to Ion Therapy.

Kathryn D Held1, Eleanor A Blakely2, Michael D Story3, Derek I Lowenstein4.   

Abstract

Although clinical studies with carbon ions have been conducted successfully in Japan and Europe, the limited radiobiological information about charged particles that are heavier than protons remains a significant impediment to exploiting the full potential of particle therapy. There is growing interest in the U.S. to build a cancer treatment facility that utilizes charged particles heavier than protons. Therefore, it is essential that additional radiobiological knowledge be obtained using state-of-the-art technologies and biological models and end points relevant to clinical outcome. Currently, most such ion radiotherapy-related research is being conducted outside the U.S. This article addresses the substantial contributions to that research that are possible at the NASA Space Radiation Laboratory (NSRL) at Brookhaven National Laboratory (BNL), which is the only facility in the U.S. at this time where heavy-ion radiobiology research with the ion species and energies of interest for therapy can be done. Here, we briefly discuss the relevant facilities at NSRL and how selected charged particle biology research gaps could be addressed using those facilities.

Entities:  

Mesh:

Year:  2016        PMID: 27195609      PMCID: PMC4937823          DOI: 10.1667/RR14412.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  10 in total

Review 1.  Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction.

Authors:  Robert Timmerman; Michael Bastasch; Debabrata Saha; Ramzi Abdulrahman; William Hittson; Michael Story
Journal:  Front Radiat Ther Oncol       Date:  2007

Review 2.  New challenges in high-energy particle radiobiology.

Authors:  M Durante
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

Review 3.  Biology of charged particles.

Authors:  Eleanor A Blakely; Polly Y Chang
Journal:  Cancer J       Date:  2009 Jul-Aug       Impact factor: 3.360

Review 4.  Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience.

Authors:  Tadashi Kamada; Hirohiko Tsujii; Eleanor A Blakely; Jürgen Debus; Wilfried De Neve; Marco Durante; Oliver Jäkel; Ramona Mayer; Roberto Orecchia; Richard Pötter; Stanislav Vatnitsky; William T Chu
Journal:  Lancet Oncol       Date:  2015-02       Impact factor: 41.316

5.  TOPAS: an innovative proton Monte Carlo platform for research and clinical applications.

Authors:  J Perl; J Shin; J Schumann; B Faddegon; H Paganetti
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

6.  Inactivation of human kidney cells by high-energy monoenergetic heavy-ion beams.

Authors:  E A Blakely; C A Tobias; T C Yang; K C Smith; J T Lyman
Journal:  Radiat Res       Date:  1979-10       Impact factor: 2.841

7.  Image-guided small animal radiation research platform: calibration of treatment beam alignment.

Authors:  Mohammad Matinfar; Eric Ford; Iulian Iordachita; John Wong; Peter Kazanzides
Journal:  Phys Med Biol       Date:  2009-01-14       Impact factor: 3.609

Review 8.  Charged particles in radiation oncology.

Authors:  Marco Durante; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2009-12-01       Impact factor: 66.675

Review 9.  Charged particle therapy--optimization, challenges and future directions.

Authors:  Jay S Loeffler; Marco Durante
Journal:  Nat Rev Clin Oncol       Date:  2013-05-21       Impact factor: 66.675

10.  Radiation-induced DNA damage in tumors and normal tissues. III. Oxygen dependence of the formation of strand breaks and DNA-protein crosslinks.

Authors:  H Zhang; C J Koch; C A Wallen; K T Wheeler
Journal:  Radiat Res       Date:  1995-05       Impact factor: 2.841

  10 in total
  6 in total

1.  Gene Expression Studies for the Development of Particle Therapy.

Authors:  Sally A Amundson
Journal:  Int J Part Ther       Date:  2018-09-21

Review 2.  National Effort to Re-Establish Heavy Ion Cancer Therapy in the United States.

Authors:  Arnold Pompos; Robert L Foote; Albert C Koong; Quynh Thu Le; Radhe Mohan; Harald Paganetti; Hak Choy
Journal:  Front Oncol       Date:  2022-06-14       Impact factor: 5.738

3.  Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma.

Authors:  Jeremy M Brownstein; Amy J Wisdom; Katherine D Castle; Yvonne M Mowery; Peter Guida; Chang-Lung Lee; Francesco Tommasino; Chiara La Tessa; Emanuele Scifoni; Junheng Gao; Lixia Luo; Lorraine Da Silva Campos; Yan Ma; Nerissa Williams; Sin-Ho Jung; Marco Durante; David G Kirsch
Journal:  Mol Cancer Ther       Date:  2018-02-07       Impact factor: 6.009

Review 4.  Metabolic Pathways of the Warburg Effect in Health and Disease: Perspectives of Choice, Chain or Chance.

Authors:  Jorge S Burns; Gina Manda
Journal:  Int J Mol Sci       Date:  2017-12-19       Impact factor: 5.923

5.  Earth-Based Research Analogs to Investigate Space-Based Health Risks.

Authors:  Ronita L Cromwell; Janice L Huff; Lisa C Simonsen; Zarana S Patel
Journal:  New Space       Date:  2021-12-20

6.  Multi-Domain Touchscreen-Based Cognitive Assessment of C57BL/6J Female Mice Shows Whole-Body Exposure to 56Fe Particle Space Radiation in Maturity Improves Discrimination Learning Yet Impairs Stimulus-Response Rule-Based Habit Learning.

Authors:  Ivan Soler; Sanghee Yun; Ryan P Reynolds; Cody W Whoolery; Fionya H Tran; Priya L Kumar; Yuying Rong; Matthew J DeSalle; Adam D Gibson; Ann M Stowe; Frederico C Kiffer; Amelia J Eisch
Journal:  Front Behav Neurosci       Date:  2021-10-11       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.